Depression and anxiety in multisomatoform disorder : prevalence and clinical predictors in primary care
Year: 2008
Type: article
Abstract: Somatisation in primary care patients is a common and disabling condition found in the populations of all countries and cultures studied. 1 Physical symptoms precipitate more than half of all primary care visits, and at least a third of such symptoms remain medically unexplained.2,3 Patients with somatisation are frequent users of medical care; and excessive clinic visits, diagnostic testing, referrals, prescriptions and procedures all contribute to increased health care costs.4,5 Somatisation results in considerable disability, impairment in various life domains, and health anxiety.5 Furthermore, the somatising patient is often dissatisfied with health care services and is rated by clinicians as being among their most difficult and unsatisfying encounters.5,6 Psychiatric co-morbidity is common in patients with somatisation.Multiple medically unexplained symptoms increase the likelihood of a co-existing psychiatric diagnosis, with as many as half of patients having an anxiety disorder, and two-thirds a depressive disorder.3,5,[7][8][9] Moreover, there is some evidence that functional impairment is higher in somatoform disorder with a co-morbid depressive or anxiety disorder.7 Multisomatoform disorder (MSD) is a diagnosis from the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Primary Care Version (DSM-IV PC), encompassing the moderately severe form of undifferentiated somatoform disorder, with a prevalence of 8 -10% in primary care.5,10 MSD is characterised by 3 or more currently troublesome medically unexplained symptoms together with a 2-year history of somatisation.If part of the criteria for a current mental disorder, physical symptoms do not count toward the diagnosis of MSD (e.g.palpitations exclusively during a panic attack).Those with MSD have impaired functioning comparable to somatisation disorder, are at increased risk for co-morbid depressive and anxiety disorders, are more prone to be unsatisfied with their health care, and are more likely to be viewed as difficult patients.3,5 The aim of this study was to evaluate the prevalence of depressive and anxiety disorders in a South African sample with MSD, and to compare various demographic and clinical outcomes between those with and without co-morbidity, based on the hypothesis that MSD with co-morbid depressive and anxiety disorders would be associated with greater functional impairment than MSD without co-morbidity.
Institutions: Stellenbosch University, University of Cape Town
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2138525958
